Capital Analysts LLC’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39K | Hold |
87
| – | – | ﹤0.01% | 874 |
|
|
2025
Q1 | $42K | Buy |
87
+10
| +13% | +$4.83K | ﹤0.01% | 830 |
|
|
2024
Q4 | $31K | Sell |
77
-3
| -4% | -$1.21K | ﹤0.01% | 847 |
|
|
2024
Q3 | $37K | Hold |
80
| – | – | ﹤0.01% | 786 |
|
|
2024
Q2 | $37K | Buy |
80
+3
| +4% | +$1.39K | ﹤0.01% | 767 |
|
|
2024
Q1 | $32K | Hold |
77
| – | – | ﹤0.01% | 750 |
|
|
2023
Q4 | $31K | Hold |
77
| – | – | ﹤0.01% | 748 |
|
|
2023
Q3 | $27K | Hold |
77
| – | – | ﹤0.01% | 729 |
|
|
2023
Q2 | $27K | Hold |
77
| – | – | ﹤0.01% | 683 |
|
|
2023
Q1 | $24K | Hold |
77
| – | – | ﹤0.01% | 706 |
|
|
2022
Q4 | $22K | Sell |
77
-19
| -20% | -$5.43K | ﹤0.01% | 745 |
|
|
2022
Q3 | $28K | Buy |
96
+19
| +25% | +$5.54K | ﹤0.01% | 669 |
|
|
2022
Q2 | $22K | Hold |
77
| – | – | ﹤0.01% | 699 |
|
|
2022
Q1 | $20K | Hold |
77
| – | – | ﹤0.01% | 675 |
|
|
2021
Q4 | $17K | Hold |
77
| – | – | ﹤0.01% | 747 |
|
|
2021
Q3 | $14K | Hold |
77
| – | – | ﹤0.01% | 754 |
|
|
2021
Q2 | $16K | Hold |
77
| – | – | ﹤0.01% | 693 |
|
|
2021
Q1 | $17K | Hold |
77
| – | – | ﹤0.01% | 734 |
|
|
2020
Q4 | $18K | Hold |
77
| – | – | ﹤0.01% | 528 |
|
|
2020
Q3 | $21K | Hold |
77
| – | – | ﹤0.01% | 500 |
|
|
2020
Q2 | $22K | Hold |
77
| – | – | ﹤0.01% | 465 |
|
|
2020
Q1 | $18K | Hold |
77
| – | – | ﹤0.01% | 463 |
|
|
2019
Q4 | $17K | Hold |
77
| – | – | ﹤0.01% | 506 |
|
|
2019
Q3 | $13K | Sell |
77
-15
| -16% | -$2.53K | ﹤0.01% | 520 |
|
|
2019
Q2 | $17K | Buy |
92
+15
| +19% | +$2.77K | ﹤0.01% | 477 |
|
|
2019
Q1 | $14K | Buy |
+77
| New | +$14K | ﹤0.01% | 482 |
|